Filing Details

Accession Number:
0001104659-12-012641
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-24 20:38:39
Reporting Period:
2012-02-23
Filing Date:
2012-02-24
Accepted Time:
2012-02-24 20:38:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008170 F Leland Wilson 1172 Castro Street
Mountain View CA 94040
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-23 77,125 $4.00 195,396 No 4 M Direct
Common Stock Disposition 2012-02-23 77,125 $20.69 118,271 No 4 S Direct
Common Stock Acquisiton 2012-02-23 72,875 $4.58 191,146 No 4 M Direct
Common Stock Disposition 2012-02-23 72,875 $20.69 118,271 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-23 77,125 $0.00 77,125 $4.00
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-23 72,875 $0.00 72,875 $4.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-01-20 No 4 M Direct
5,027 2014-01-26 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2010.
  2. The option is fully vested and immediately exercisable.